Imexpharm Corporation (HOSE:IMP)
Vietnam flag Vietnam · Delayed Price · Currency is VND
37,650
+150 (0.40%)
At close: Aug 13, 2026

Imexpharm Ratios and Metrics

Millions VND. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
5,798,4378,085,4717,238,4213,962,1674,013,6285,187,048
Market Cap Growth
-28.96%11.70%82.69%-1.28%-22.62%38.19%
Enterprise Value
5,490,1308,062,6717,072,1953,840,8343,828,5145,172,206
Last Close Price
37650.0051735.4445871.9024801.6724761.5331286.47

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
PE Ratio
18.4526.5626.2414.2621.8329.89
Forward PE
16.3422.9720.3011.6819.0021.00
PS Ratio
2.503.313.281.992.444.10
PB Ratio
2.483.513.321.902.122.89
P/TBV Ratio
2.563.623.431.972.203.01
P/FCF Ratio
23.05296.2660.57-14.3728.50
P/OCF Ratio
20.14149.2633.47-10.6022.08
PEG Ratio
-1.991.991.992.710.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
EV/Sales Ratio
2.363.303.211.932.334.08
EV/EBITDA Ratio
9.6614.2613.588.2810.7317.56
EV/EBIT Ratio
11.7517.4317.0410.0812.9122.10
EV/FCF Ratio
21.82295.4259.18-13.7128.42

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Debt / Equity Ratio
0.080.090.040.020.050.15
Debt / EBITDA Ratio
0.340.380.170.110.270.90
Debt / FCF Ratio
0.787.800.72-0.341.45
Net Debt / Equity Ratio
-0.13-0.08-0.10-0.07-0.16-0.07
Net Debt / EBITDA Ratio
-0.54-0.33-0.42-0.32-0.83-0.41
Net Debt / FCF Ratio
-1.23-6.91-1.821.45-1.06-0.66
Asset Turnover
0.780.920.900.850.720.58
Inventory Turnover
1.811.851.681.781.781.46
Quick Ratio
1.921.962.001.491.621.56
Current Ratio
3.364.054.383.922.892.88
Return on Equity (ROE)
16.15%15.55%15.04%15.06%12.12%10.73%
Return on Assets (ROA)
9.78%10.93%10.60%10.20%8.11%6.66%
Return on Invested Capital (ROIC)
17.77%17.72%16.90%17.12%13.89%10.94%
Return on Capital Employed (ROCE)
19.10%19.20%19.00%18.30%15.70%12.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Earnings Yield
5.42%4.32%4.43%7.56%5.57%3.65%
FCF Yield
4.34%0.34%1.65%-2.60%6.96%3.51%
Dividend Yield
1.33%-1.09%1.83%1.75%2.08%
Payout Ratio
21.37%22.05%21.82%22.26%44.74%52.89%
Buyback Yield / Dilution
3.93%--0.00%0.00%-2.92%
Total Shareholder Return
5.27%-1.09%1.83%1.75%-0.84%